Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Lupus ; 24(13): 1384-91, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26082465

RESUMO

OBJECTIVE: The aim of this study was to evaluate the effect of hydroxychloroquine (HCQ) on fetal preterm delivery and intrauterine growth restriction (IUGR) in a cohort of pregnant women with systemic lupus erythematosus (SLE). METHODS: Over an 11-year period (January 1, 2001 to December 31, 2011), all women with SLE and admitted to deliver after 22 weeks of gestation to Bordeaux University Hospital (France), were retrospectively enrolled in the present study. The population was then split into two groups based on the treatment they received: HCQ exposed (HCQ+) versus HCQ non-exposed (HCQ-) group. RESULTS: 118 pregnancies were included, 41 in the HCQ+ group and 77 in the HCQ- group. The rate of adverse fetal outcome was significantly lower in the HCQ+ group (p = 0.001), particularly in terms of preterm delivery, 15.8% versus 44.2% (p = 0.006), and IUGR, 10.5% versus 28.6% (p = 0.03). No adverse outcomes were reported in the HCQ+ group. CONCLUSION: HCQ reduces neonatal morbidity in women with SLE by significantly decreasing the rate of prematurity and intrauterine growth restriction.


Assuntos
Antirreumáticos/efeitos adversos , Retardo do Crescimento Fetal/induzido quimicamente , Retardo do Crescimento Fetal/diagnóstico , Hidroxicloroquina/efeitos adversos , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Complicações na Gravidez/induzido quimicamente , Complicações na Gravidez/tratamento farmacológico , Nascimento Prematuro/induzido quimicamente , Adulto , Antirreumáticos/administração & dosagem , Estudos de Coortes , Feminino , Idade Gestacional , Glucocorticoides/administração & dosagem , Humanos , Hidroxicloroquina/administração & dosagem , Recém-Nascido Prematuro , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Gravidez , Complicações na Gravidez/prevenção & controle , Resultado da Gravidez , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença
2.
Diagn Microbiol Infect Dis ; 82(1): 14-9, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25753079

RESUMO

Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium screening during pregnancy is not performed routinely in France. We conducted the first prospective study in 1004 women attending for routine antenatal care to determine the prevalence and risk factors for these bacterial infections. The overall prevalence of C. trachomatis, N. gonorrhoeae, and M. genitalium infections was 2.5%, 0%, and 0.8%, respectively. In patients aged 18-24 years, the prevalence increased to 7.9% for C. trachomatis and to 2.4% for M. genitalium. C. trachomatis infection was associated with age ≤24 years or being single or having more than 5 sexual partners in a lifetime. M. genitalium infection was more frequent in patients aged ≤24 years or who had a history of abortion or their first sexual intercourse after 20 years of age. The high prevalence of C. trachomatis in pregnant women aged ≤24 years, mostly asymptomatic, suggests that systematic screening could be beneficial.


Assuntos
Infecções por Chlamydia/epidemiologia , Testes Diagnósticos de Rotina/métodos , Gonorreia/epidemiologia , Infecções por Mycoplasma/epidemiologia , Complicações Infecciosas na Gravidez/diagnóstico , Diagnóstico Pré-Natal/métodos , Adolescente , Adulto , Fatores Etários , Infecções por Chlamydia/diagnóstico , Chlamydia trachomatis/isolamento & purificação , Feminino , França/epidemiologia , Gonorreia/diagnóstico , Humanos , Infecções por Mycoplasma/diagnóstico , Mycoplasma genitalium/isolamento & purificação , Neisseria gonorrhoeae/isolamento & purificação , Gravidez , Prevalência , Estudos Prospectivos , Adulto Jovem
4.
Br J Haematol ; 112(1): 51-4, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11167783

RESUMO

Hereditary hyperferritinaemia cataract syndrome (HHCS) is characterized by hyperferritinaemia without iron overload. It is essential to differentiate true iron accumulation from HHCS as these patients rapidly develop iron-deficient anaemia when subjected to phlebotomies. The diagnosis of HHCS relies on the identification of point mutations or deletions present in the iron-responsive element of the first exon of the L-ferritin gene. However, many samples referred for diagnosis of putative HHCS are normal. To avoid unnecessary DNA sequencing, we have developed a diagnosis strategy based on the screening of the target DNA region by denaturing gradient gel electrophoresis. This method enabled the accurate identification of 11 different previously known mutations. This strategy will be of interest for family studies or for the screening of large series of patients.


Assuntos
Catarata/genética , Ferritinas/sangue , Regiões 5' não Traduzidas , Análise Mutacional de DNA/métodos , Eletroforese em Gel de Poliacrilamida/métodos , Humanos , Mutação , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA